{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:16:35Z","timestamp":1788264995888,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.semarthrit.2016.11.002","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T03:00:25Z","timestamp":1479178825000},"page":"657-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial"],"prefix":"10.1016","volume":"46","author":[{"given":"Katie","family":"Tuckwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Collinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dimonaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micki","family":"Klearman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blockmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian H.","family":"Unizony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.11.002_bib1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1056\/NEJMcp1214825","article-title":"Clinical practice: giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/acr.22429","article-title":"Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities","volume":"67","author":"Petri","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib4","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/08820530902805776","article-title":"Giant cell arteritis and angiogenesis: a review","volume":"24","author":"Mitchell","year":"2009","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.0954-6820.1986.tb02796.x","article-title":"Long-term corticosteroid treatment in giant cell arteritis","volume":"220","author":"Andersson","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib9","first-page":"495","article-title":"A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Martinez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib13","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/annrheumdis-2013-203586","article-title":"Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial","volume":"73","author":"Seror","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 10","key":"10.1016\/j.semarthrit.2016.11.002_bib14","article-title":"A randomized double-blind trial of abatacept and glucocorticoids for the treatment of giant cell arteritis","volume":"67","author":"Langford","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib15","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet"},{"issue":"Suppl 10","key":"10.1016\/j.semarthrit.2016.11.002_bib16","article-title":"Tocilizumab for the treatment of giant cell arteritis\u2014a randomized placebo-controlled trial","volume":"67","author":"Adler","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11926-010-0135-9","article-title":"Llorca J. Giant cell arteritis: epidemiology, diagnosis, and management","volume":"12","author":"Gonzalez-Gay","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib19","first-page":"1186","article-title":"The diagnosis and management of patients with giant cell arteritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1308\/003588411X12851639107476","article-title":"The role of temporal artery biopsies in giant cell arteritis","volume":"93","author":"Davies","year":"2011","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.rdc.2014.10.001","article-title":"Advances in the diagnosis of large vessel vasculitis","volume":"41","author":"Espigol-Frigole","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib22","doi-asserted-by":"publisher","first-page":"914692","DOI":"10.1155\/2015\/914692","article-title":"Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET\/CT","volume":"2015","author":"Lensen","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/rheumatology\/kem379","article-title":"Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update","volume":"47","author":"Pipitone","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib24","doi-asserted-by":"crossref","first-page":"912562","DOI":"10.1155\/2013\/912562","article-title":"Design of the tocilizumab in giant cell arteritis trial","volume":"2013","author":"Unizony","year":"2013","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib25","doi-asserted-by":"crossref","first-page":"589841","DOI":"10.1155\/2015\/589841","article-title":"Development and implementation of a double-blind corticosteroid-tapering regimen for a clinical trial","volume":"2015","author":"Collinson","year":"2015","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.22777","article-title":"Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica","volume":"57","author":"Hutchings","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib29","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(83)91269-2","article-title":"The therapeutic impact of temporal artery biopsy","volume":"2","author":"Hall","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib30","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.ophtha.2013.01.052","article-title":"A national survey of practice patterns: temporal artery biopsy","volume":"120","author":"Schallhorn","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib31","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s10067-016-3221-1","article-title":"Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy","volume":"35","author":"Grossman","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.11.002_bib32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721630275X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721630275X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T11:55:37Z","timestamp":1568548537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901721630275X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S004901721630275X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.11.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}